| Oxidative stress and antioxidant status in non-metastatic prostate cancer and benign prostatic hyperplasia A Aydin, Z Arsova-Sarafinovska, A Sayal, A Eken, O Erdem, K Erten, ... Clinical biochemistry 39 (2), 176-179, 2006 | 270 | 2006 |
| Increased oxidative/nitrosative stress and decreased antioxidant enzyme activities in prostate cancer Z Arsova-Sarafinovska, A Eken, N Matevska, O Erdem, A Sayal, ... Clinical biochemistry 42 (12), 1228-1235, 2009 | 168 | 2009 |
| Mutational signature analysis reveals NTHL1 deficiency to cause a multi-tumor phenotype JE Grolleman, RM De Voer, FA Elsayed, M Nielsen, RDA Weren, C Palles, ... Cancer cell 35 (2), 256-266. e5, 2019 | 157 | 2019 |
| Glutathione peroxidase 1 (GPX1) genetic polymorphism, erythrocyte GPX activity, and prostate cancer risk Z Arsova-Sarafinovska, N Matevska, A Eken, D Petrovski, S Banev, ... International urology and nephrology 41 (1), 63-70, 2009 | 143 | 2009 |
| Sequence variations in the 5'flanking and IVS-II regions of the G gamma-and A gamma-globin genes of beta S chromosomes with five different haplotypes KD Lanclos, C Oner, AJ Dimovski, YC Gu, TH Huisman | 118 | 1991 |
| Sequence variations in the 5'hypersensitive site-2 of the locus control region of beta S chromosomes are associated with different levels of fetal globin in hemoglobin S … C Oner, AJ Dimovski, C Altay, A Gurgey, YC Gu, TH Huisman, KD Lanclos | 110 | 1992 |
| βS haplotypes in various world populations C Öner, AJ Dimovski, NF Olivieri, G Schiliro, JF Codrington, S Fattoum, ... Human Genetics 89 (1), 99-104, 1992 | 108 | 1992 |
| Higher-order connections between stereotyped subsets: implications for improved patient classification in CLL A Agathangelidis, A Chatzidimitriou, K Gemenetzi, V Giudicelli, ... Blood, The Journal of the American Society of Hematology 137 (10), 1365-1376, 2021 | 107 | 2021 |
| Loss of Y chromosome in peripheral blood of colorectal and prostate cancer patients P Noveski, S Madjunkova, E Sukarova Stefanovska, ... PloS one 11 (1), e0146264, 2016 | 104 | 2016 |
| Hb adana or α259(E8)Gly→Aspβ2, A severely unstable α1‐globin variant, observed in combination with the ‐(α)20.5 KB α‐thal‐1 deletion in two Turkish patients MA Cürük, AJ Dimovski, E Baysal, LH Gu, F Kutlar, TP Molchanova, ... American journal of hematology 44 (4), 270-275, 1993 | 90 | 1993 |
| How polymorphisms of the cytochrome P450 genes affect ibuprofen and diclofenac metabolism and toxicity/Kako polimorfizmi gena citokroma P450 utječu na metabolizam i toksičnost … V Krasniqi, A Dimovski, IK Domjanović, I Bilić, N Božina Archives of Industrial Hygiene and Toxicology 67 (1), 1-8, 2016 | 58 | 2016 |
| The-158 (C--> T) promoter mutation is responsible for the increased transcription of the 3'gamma gene in the Atlanta type of hereditary persistence of fetal hemoglobin DG Efremov, AJ Dimovski, TH Huisman | 56 | 1994 |
| An Alu insert as the cause of a severe form of hemophilia A E Sukarova, AJ Dimovski, P Tchacarova, GH Petkov, GD Efremov Acta haematologica 106 (3), 126-129, 2001 | 55 | 2001 |
| Manganese superoxide dismutase (MnSOD) genetic polymorphism is associated with risk of early‐onset prostate cancer Z Arsova‐Sarafinovska, N Matevska, D Petrovski, S Banev, S Dzikova, ... Cell Biochemistry and Function: Cellular biochemistry and its modulation by …, 2008 | 53 | 2008 |
| β-Thalassemia in Bulgaria GH Petkov, GD Efremov, DG Efremov, A Dimovski, P Tchaicarova, ... Hemoglobin 14 (1), 25-33, 1990 | 52 | 1990 |
| β-Thalassemia in Yugoslavia A Dimovski, DG Efremov, L Jankovic, GD Efremov, D Juricic, N Zisovski, ... Hemoglobin 14 (1), 15-24, 1990 | 48 | 1990 |
| B-cell receptor signaling and genetic lesions in TP53 and CDKN2A/CDKN2B cooperate in Richter transformation S Chakraborty, C Martines, F Porro, I Fortunati, A Bonato, M Dimishkovska, ... Blood, The Journal of the American Society of Hematology 138 (12), 1053-1066, 2021 | 46 | 2021 |
| The G----A mutation at position+ 22 3'to the Cap site of the beta-globin gene as a possible cause for a beta-thalassemia. R Oner, S Agarwal, AJ Dimovski, GD Efremov, GH Petkov, C Altay, ... Hemoglobin 15 (1-2), 67-76, 1991 | 44 | 1991 |
| Association of GPX1 polymorphism, GPX activity and prostate cancer risk O Erdem, A Eken, C Akay, Z Arsova-Sarafinovska, N Matevska, ... Human & experimental toxicology 31 (1), 24-31, 2012 | 42 | 2012 |
| Promoter length polymorphism in UGT1A1 and the risk of sporadic colorectal cancer MH Bajro, T Josifovski, M Panovski, N Jankulovski, AK Nestorovska, ... Cancer genetics 205 (4), 163-167, 2012 | 37 | 2012 |
Nadica Matevska-GeshkovskaSs. Cyril and Methodius University in Skopje, Faculty of Pharmacyff.ukim.edu.mk üzerinde doğrulanmış e-posta adresine sahip
